What could be the impact of proposed new ‘budget impact threshold’ for drugs?
Will NICE introduce fees for pharma companies’ TAs from next year?
NICE plans to charge for appraisals – but pharma wants reform first
NICE needs to plug a gap in its funding
Should industry pay for NICE Technology Appraisals?